Sibold L, Guiso N, de Beuckeleer M, Van Montagu M
Biochimie. 1984 Jul-Aug;66(7-8):547-56. doi: 10.1016/0300-9084(84)90149-4.
A plasmid was constructed that directs expression of the TL-DNA gene 4 protein in E. coli. The different steps of the construction were as follows: i) a region of gene 4 encoding the amino-terminal portion of the protein was fused in frame to DNA encoding an enzymatically active carboxy-terminal fragment of beta-galactosidase. The hybrid gene was poorly expressed from the upstream lambda PL promoter carried by the vector. ii) in order to generate an efficient procaryotic ribosome binding site, a DNA fragment carrying the lambda PR promoter with the nearby Shine-Dalgarno (SD) sequence of gene cro was placed in front of the gene 4-lacZ fusion. A recombinant plasmid, termed pGV793, that expressed efficiently a fused protein 4-beta-galactosidase was identified among the Lac+ clones. DNA sequencing analysis showed that pGV793 carried a hybrid ribosome binding site composed of the cro SD sequence, a five bp sequence and the ATG codon of gene 4. Plasmid pGV793 directed the synthesis of three polypeptides of molecular weight 132 Kd, 126 Kd and 122 Kd that carried beta-galactosidase antigenic determinants. The largest polypeptide had the expected size for the hybrid protein. The fusion proteins which accounted for about 0.5% of the total cellular proteins were purified by immunoadsorption using anti-beta-galactosidase antiserum. iii) the complete gene 4 coding sequence was reconstituted, with the lambda PR promoter in place. The resulting pGV822 plasmid expressed a polypeptide whose molecular weight 27 Kd corresponded to the expected size for the gene 4 product. The pI was about 7.
构建了一种质粒,可在大肠杆菌中指导TL-DNA基因4蛋白的表达。构建过程的不同步骤如下:i)将编码该蛋白氨基末端部分的基因4区域与编码β-半乳糖苷酶具有酶活性的羧基末端片段的DNA框内融合。载体携带的上游λPL启动子对该杂交基因的表达效果不佳。ii)为了产生有效的原核核糖体结合位点,将携带λPR启动子及附近cro基因的Shine-Dalgarno(SD)序列的DNA片段置于基因4-lacZ融合体之前。在Lac+克隆中鉴定出一种重组质粒,称为pGV793,它能高效表达融合蛋白4-β-半乳糖苷酶。DNA测序分析表明,pGV793携带一个由cro SD序列、一个5bp序列和基因4的ATG密码子组成的杂交核糖体结合位点。质粒pGV793指导合成了分子量为132 Kd、126 Kd和122 Kd的三种多肽,它们带有β-半乳糖苷酶抗原决定簇。最大的多肽具有杂交蛋白预期的大小。约占细胞总蛋白0.5% 的融合蛋白通过使用抗β-半乳糖苷酶抗血清的免疫吸附进行纯化。iii)完整的基因4编码序列得以重构,λPR启动子也已就位。所得的pGV822质粒表达了一种分子量为27 Kd的多肽,与基因4产物的预期大小相符。其pI约为7。